Evidence map›Paper›PMID 32595403›Full record

ArticleSisli Etfal Hastanesi tip bulteni2018

A Rare Tumor in Childhood Desmoplastic Infantile Astrocytoma: Two Case Reports.

Canan Tanık, Elif Gökçe Devecioğlu, Seyhan Hasçiçek, Songül Meltem Can, Ahmet Mesrur Halefoğlu, Fevziye Kabukçuoğlu

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Sisli Etfal Hastanesi tip bulteni, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 72% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Canan TanıkDepartment of Pathology, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.
Elif Gökçe DevecioğluDepartment of Pathology, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.
Seyhan HasçiçekDepartment of Pathology, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.
Songül Meltem CanDepartment of Neurology, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.
Ahmet Mesrur HalefoğluDepartment of Radiology, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.
Fevziye KabukçuoğluDepartment of Pathology, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.
Şişli Etfal Eğitim ve Araştırma Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Desmoplastic infantile astrocytomas (DIAs), are rare supratentorial tumors, usually observed in the first 24 months of life. Despite their aggressive appearance, they tend to follow a favorable clinical course. Total or near total resection of tumor is usually the treatment option. Desmoplastic Infantile Ganglioglioma (DIG) and DIA are WHO grade I tumors that have similar clinical and morphological findings. The only criterion in differential diagnosis is the neural component of DIG. These tumors both have dense fibroblastic stroma and positive staining with glial fibrillar acidic protein (GFAP) and CD34. A rare case of desmoplastic infantile astrocytoma presenting with right side partial seizures presented in a 1-year-old child. A rare case of desmoplastic infantile astrocytoma presenting with focal onset generalized seizures presented in a 1-year-old child. Despite their radiological and histological properties, these tumors have a benign course. After 3-year follow-up for the first case and 1-year follow-up for the second case, there was no recurrence.

Indexed as

Desmoplastic infantile astrocytomafavorable prognosissupratentorial

Identifiers

PMID32595403
PMCPMC7315091
OpenAlexW2981411287

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.